IGF1 and coronary artery disorder: Prior clinical research has implied that hypoxia and inflammation lead to downregulation of IGF‐1 and IGFBP‐317, 18, 19, 20, 21, 22, which has been associated with impaired somatic growth in CHD as well as reduced neonatal brain volume and poorer neurodevelopmental outcomes in preterm infants.23, 24, 25, 26, 27, 28